Canadian Blood Services discovery research lab contributes to new knowledge on neutrophils

Dr. Donald R. Branch’s work as a discovery scientist at Canadian Blood Services focuses on immunotherapy, seeking to further enhance understanding of the cellular and molecular mechanisms involved in autoimmune diseases. Based in Toronto, Dr. Branch’s laboratory develops models of rheumatoid arthritis, Alzheimer’s disease, immune thrombocytopenia (ITP) and multiple sclerosis in mice. These models are particularly useful in examining how cells affected by these conditions respond to current therapeutic agents like intravenous immunoglobulin – a blood product made from human plasma commonly
August 29, 2024

Aug 28
1:00 pm | Virtual/Vancouver

Seminar Series: What is a Hematologist?

This lecture is part of the CBR lecture series. Held on Wednesdays from 1-2pm PT, CBR seminars feature insightful scientific talks, with speakers from a range of clinical, industry and academic backgrounds. Hematology is that branch of medicine concerned with the clinical and laboratory

Aug 21
1:00 pm | Virtual/Vancouver

Seminar Series: Working towards robust, portable, point-of-need diagnostics using silicon photonic biosensors, microfluidics design, and immunoassay development

This lecture is part of the CBR lecture series. Held on Wednesdays from 1-2pm PT, CBR seminars feature insightful scientific talks, with speakers from a range of clinical, industry and academic backgrounds. Diagnostics at the point-of-need remain an important goal in the post-pandemic world. In

Sep 6
12:00 pm | Virtual

The International Collaboration for Transfusion Medicine Guidelines’ (ICTMG) Use of Intravenous Albumin guideline: Moving evidence into practice

Join the third Breakthroughs in blood: Advancements into action 1.5 hour webinar as Dr. Sheharyar Raza discusses Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines published in the peer reviewed journal CHEST in March 2024. Albumin is

Driving excellence: The Centre for Blood Research and Canadian Blood Services renew collaboration to advance blood science education and training

This blog was originally prepared by CBR communications and programs coordinator Kaitlyn Chuong and former Canadian Blood Services knowledge broker Dr. Travis Sztainert, with edits provided by Abby Wolfe. After more than 20 years, the Centre for Blood Research (CBR) and Canadian Blood Services are proud to share that they have renewed their collaboration agreement which supports education, training and knowledge mobilization for the next generation of trainees and researchers in blood science and transfusion at CBR. The collaboration agreement which is administered by Innovation and Portfolio
July 30, 2024

Aug 7
1:00 pm | Virtual/Vancouver

Seminar Series: Do adult-derived biomarkers have similar utility in pediatric small vessel vasculitis?

This lecture is part of the CBR lecture series. Held on Wednesdays from 1-2pm PT, CBR seminars feature insightful scientific talks, with speakers from a range of clinical, industry and academic backgrounds. Vasculitis describes a group of rare diseases caused by inflammation and necrosis of blood

Aug 7
2:00 pm | Virtual

Ensuring Blood Safety and Protecting Public Health: Navigating Emerging Infectious Diseases

Join AABB, as they provide context for the recently published AABB Emerging Infectious Diseases (EID) Fact Sheets. Last published in 2009, these highly cited Fact Sheets describe 72 infectious agents in detail (including, but not limited to, respiratory and sexually transmitted diseases), include

Aug 23
8:30 am | Toronto

4th Annual SCAGO Sickle Cell Summit

This year's summit will be held in-person on August 23rd and 24th, 2024 at DoubleTree by Hilton Hotel Toronto Airport West (5444 Dixie Rd. Mississauga ON, L4W 2L2), and will focus on the theme of Innovative Cures for Sickle Cell Disease (SCD). This summit aims to bring together the diverse members

Jul 11
12:00 pm | Virtual

Systematic reviews and meta-analyses

The Canadian Transfusion Trials Group (CTTG) is a pioneering national initiative designed to promote collaboration and excellence in Transfusion Medicine research. CTTG, led by co-directors Drs. Donald Arnold and Jeannie Callum, represents a paradigm shift in transfusion medicine research. CTTG

Dec 7
7:00 am | San Diego/Virtual

66th Annual Meeting and Exposition

The 66th American Society of Hematology (ASH) Annual Meeting and Exposition is scheduled to take place December 7-10, 2024 in San Diego, California, and online. Registration For further event information and registration details, including important registration and abstract submission deadlines